Featured Stories

Emil Lou microscope
One patient who will always stick with Masonic Scholar Emil Lou, M.D., Ph.D., is a 51-year-old man he treated with a rare and incurable form of brain cancer called medulloblastoma. “This man was... Read more
Balbo Lab
In addition to causing side effects such as vomiting or hair loss, chemotherapy is thought to play a significant role in how patients respond to blood and marrow transplantation, impacting everything... Read more

Masonic Cancer Center Facebook

U of M Masonic Children's Hospital Facebook